BETA 13 PHARMACEUTICAL LIMITED
Copy
CopyKey Data
Status
Company No.
Incorporation date
Size
Classification
Contacts
Registered address
Copy
No eventsTotal Assets
No recordsNumber of employees
No recordsCash in Bank
No recordsConfirmation
Accounts
AccountsFinancial Ratios
No financial ratios available
This company has not submitted financial statements or the data is not publicly available. Please check back later – the information may be updated.
People
Officers
Person  | Title | Period | Connections |
|---|---|---|---|
Ragone, Carlos Jose | Director | 27/11/2020 - Present | 11 |
Persons with Significant Control
Persons with Significant Control
This information is available in our reports and to subscription users.Similar companies
Category:
Raising of other animalsComp. code:
13722288Reg. date:
03/11/2021Turnover:
-No. of employees:
-Category:
Hunting trapping and related service activitiesComp. code:
14414705Reg. date:
12/10/2022Turnover:
-No. of employees:
-Category:
Growing of riceComp. code:
14414816Reg. date:
12/10/2022Turnover:
-No. of employees:
-Category:
Silviculture and other forestry activitiesComp. code:
07862250Reg. date:
28/11/2011Turnover:
-No. of employees:
-Category:
Growing of riceComp. code:
14414821Reg. date:
12/10/2022Turnover:
-No. of employees:
-Description
CopyAbout BETA 13 PHARMACEUTICAL LIMITED
BETA 13 PHARMACEUTICAL LIMITED is an(a) Dissolved company incorporated on 27/11/2020 with the registered office located at 24 Chirnside Court, Blantyre, Glasgow G72 0YN. There is currently 1 active director according to the latest confirmation statement. Number of employees Unknown.Frequently Asked Questions
What is the current status of BETA 13 PHARMACEUTICAL LIMITED?
BETA 13 PHARMACEUTICAL LIMITED is currently Dissolved. It was registered on 27/11/2020 and dissolved on 03/05/2022.
Where is BETA 13 PHARMACEUTICAL LIMITED located?
BETA 13 PHARMACEUTICAL LIMITED is registered at 24 Chirnside Court, Blantyre, Glasgow G72 0YN.
What does BETA 13 PHARMACEUTICAL LIMITED do?
BETA 13 PHARMACEUTICAL LIMITED operates in the Manufacture of basic pharmaceutical products (21.10 - SIC 2007) sector.